T1	tradename 112 120	ELESTRIN
T2	tradename 183 202	ELESTRIN. Elestrin
T3	activeingredient 204 213	estradiol
T4	dose 225 232	0.52 mg
T5	activeingredient 236 245	estradiol
T6	fdaapprovaldate 283 287	1975
T7	adversereaction 298 358	ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER
T8	adversereaction 363 380	PROBABLE DEMENTIA
T9	adversereaction 508 526	endometrial cancer
T10	tradename 1714 1714	
T11	indication 1787 1823	Vasomotor Symptoms due to Menopause
T12	dose 1989 1996	0.52 mg
T13	activeingredient 1997 2007	estradiol,
T14	dose 2075 2082	1.04 mg
T15	activeingredient 2083 2092	estradiol
T16	tradename 2184 2184	
T17	dose 2242 2249	0.52 mg
T18	activeingredient 2253 2262	estradiol
T19	tradename 2803 2811	ELESTRIN
T20	adversereaction 3140 3159	gallbladder disease
T21	adversereaction 3207 3237	hypercalcemia, loss of vision,
T22	adversereaction 3246 3266	hypertriglyceridemia
T23	adversereaction 3270 3290	cholestatic jaundice
T24	adversereaction 3627 3676	breast tenderness, metrorrhagia, nasopharyngitis,
T25	adversereaction 3681 3716	upper respiratory tract infections.
T26	company 3771 3775	Meda
T27	adversereaction 4777 4836	ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER
T28	adversereaction 4841 4858	PROBABLE DEMENTIA
T29	indication 4914 4957	Severe Vasomotor Symptoms due to Menopause
T30	indication 5026 5062	Vasomotor Symptoms due to Menopause
T31	adversereaction 5146 5170	Cardiovascular Disorders
T32	adversereaction 5177 5196	Malignant Neoplasms
T33	adversereaction 5203 5220	Probable Dementia
T34	adversereaction 5227 5246	Gallbladder Disease
T35	adversereaction 5253 5266	Hypercalcemia
T36	adversereaction 5273 5293	Visual Abnormalities
T37	adversereaction 5372 5395	Elevated Blood Pressure
T38	adversereaction 5402 5422	Hypertriglyceridemia
T39	adversereaction 5471 5491	Cholestatic Jaundice
T40	adversereaction 5498 5512	Hypothyroidism
T41	adversereaction 5519 5534	Fluid Retention
T42	adversereaction 5541 5553	Hypocalcemia
T43	adversereaction 5560 5589	Exacerbation of Endometriosis
T44	adversereaction 7038 7098	ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER
T45	adversereaction 7103 7120	PROBABLE DEMENTIA
T46	adversereaction 7147 7165	Endometrial Cancer
T47	adversereaction 7197 7215	endometrial cancer
T48	adversereaction 7348 7372	endometrial hyperplasia,
T49	adversereaction 7401 7420	endometrial cancer.
T50	adversereaction 7693 7717	Cardiovascular Disorders
T51	adversereaction 7722 7739	Probable Dementia
T52	adversereaction 7805 7827	cardiovascular disease
T53	adversereaction 7831 7839	dementia
T54	frequency 8128 8133	daily
T55	routeofadministration 8134 8138	oral
T56	dose 8166 8175	0.625 mg]
T57	adversereaction 8384 8401	probable dementia
T58	duration 8458 8467	5.2 years
T59	frequency 8486 8491	daily
T60	dose 8496 8505	0.625 mg)
T61	adversereaction 9186 9208	cardiovascular disease
T62	adversereaction 9212 9220	dementia
T63	duration 9598 9607	5.6 years
T64	frequency 9626 9631	daily
T65	routeofadministration 9632 9636	oral
T66	dose 9641 9650	0.625 mg)
T67	dose 9700 9707	2.5 mg]
T68	adversereaction 9899 9916	probable dementia
T69	duration 9973 9980	4 years
T70	frequency 9999 10004	daily
T71	dose 10009 10018	0.625 mg)
T72	adversereaction 10342 10364	invasive breast cancer
T73	indication 10861 10896	Vasomotor Symptoms due to Menopause
T74	adversereaction 11068 11087	endometrial cancer.
T75	routeofadministration 11742 11763	applied onto the skin
T76	indication 11909 11944	Vasomotor Symptoms due to Menopause
T77	tradename 11946 11954	ELESTRIN
T78	frequency 11966 11976	once daily
T79	indication 12034 12069	vasomotor symptoms due to menopause
T80	dose 12111 12120	0.87 gram
T81	activeingredient 12124 12133	estradiol
T82	dose 12139 12146	0.52 mg
T83	activeingredient 12147 12157	estradiol)
T84	tradename 12244 12253	ELESTRIN,
T85	frequency 12272 12279	per day
T86	dose 12281 12287	0.87 g
T87	frequency 12288 12296	per day,
T88	dose 12312 12319	0.52 mg
T89	activeingredient 12323 12333	estradiol)
T90	tradename 12525 12533	Elestrin
T91	activeingredient 12535 12544	estradiol
T92	dose 12607 12614	0.52 mg
T93	activeingredient 12618 12627	estradiol
T94	dose 12631 12637	0.87 g
T95	tradename 12686 12694	ELESTRIN
T96	tradename 13153 13161	ELESTRIN
T97	adversereaction 13387 13411	Cardiovascular Disorders
T98	adversereaction 13434 13440	stroke
T99	adversereaction 13445 13448	DVT
T100	adversereaction 13639 13654	PE, DVT, stroke
T101	adversereaction 13659 13661	MI
T102	adversereaction 14240 14246	stroke
T103	frequency 14301 14306	daily
T104	dose 14311 14320	0.625 mg)
T105	adversereaction 14527 14533	stroke
T106	adversereaction 14695 14701	stroke
T107	dose 14732 14741	0.625 mg)
T108	frequency 14972 14977	daily
T109	dose 14982 14991	0.625 mg)
T110	dose 15002 15009	2.5 mg)
T111	adversereaction 15320 15342	Coronary Heart Disease
T112	adversereaction 15401 15429	coronary heart disease (CHD)
T113	dose 15705 15714	0.625 mg]
T114	frequency 15975 15980	daily
T115	dose 15985 15994	0.625 mg)
T116	dose 16005 16012	2.5 mg)
T117	frequency 16498 16503	daily
T118	dose 16508 16517	0.625 mg)
T119	dose 16528 16535	2.5 mg)
T120	adversereaction 17381 17403	Venous Thromboembolism
T121	frequency 17504 17509	daily
T122	dose 17514 17523	0.625 mg)
T123	frequency 18029 18034	daily
T124	dose 18039 18048	0.625 mg)
T125	dose 18059 18066	2.5 mg)
T126	adversereaction 18721 18760	Malignant Neoplasms Endometrial Cancer
T127	adversereaction 18783 18801	endometrial cancer
T128	adversereaction 20092 20116	endometrial hyperplasia,
T129	adversereaction 20145 20164	endometrial cancer.
T130	tradename 20259 20267	ELESTRIN
T131	dose 20268 20273	1.7 g
T132	frequency 20274 20281	per day
T133	adversereaction 20289 20302	Breast Cancer
T134	adversereaction 20377 20390	breast cancer
T135	frequency 20438 20443	daily
T136	dose 20448 20457	0.625 mg)
T137	frequency 20546 20551	daily
T138	adversereaction 20606 20628	invasive breast cancer
T139	adversereaction 20761 20774	breast cancer
T140	frequency 20831 20836	daily
T141	dose 20841 20850	0.625 mg)
T142	dose 20861 20868	2.5 mg)
T143	adversereaction 20975 20997	invasive breast cancer
T144	frequency 21016 21021	daily
T145	adversereaction 21180 21202	invasive breast cancer
T146	adversereaction 21398 21420	invasive breast cancer
T147	adversereaction 21619 21641	invasive breast cancer
T148	adversereaction 21783 21806	invasive breast cancers
T149	dose 21913 21922	0.625 mg)
T150	dose 21933 21940	2.5 mg)
T151	adversereaction 22706 22719	breast cancer
T152	adversereaction 24258 24275	Probable Dementia
T153	frequency 24413 24418	daily
T154	dose 24423 24432	0.625 mg)
T155	frequency 25031 25036	daily
T156	dose 25041 25050	0.625 mg)
T157	dose 25061 25068	2.5 mg)
T158	adversereaction 25209 25227	probable dementia.
T159	adversereaction 25250 25267	probable dementia
T160	adversereaction 25351 25368	probable dementia
T161	adversereaction 25711 25728	probable dementia
T162	adversereaction 25987 26006	Gallbladder Disease
T163	adversereaction 26047 26066	gallbladder disease
T164	adversereaction 26260 26273	Hypercalcemia
T165	adversereaction 26318 26331	hypercalcemia
T166	adversereaction 26385 26398	hypercalcemia
T167	adversereaction 26512 26561	Visual Abnormalities Retinal vascular thrombosis
T168	adversereaction 26673 26708	partial or complete loss of vision,
T169	adversereaction 26730 26750	proptosis, diplopia,
T170	adversereaction 26754 26763	migraine.
T171	adversereaction 26788 26799	papilledema
T172	adversereaction 26803 26828	retinal vascular lesions,
T173	adversereaction 27444 27458	breast cancer.
T174	adversereaction 27464 27487	Elevated Blood Pressure
T175	adversereaction 27536 27563	increases in blood pressure
T176	adversereaction 27757 27777	Hypertriglyceridemia
T177	adversereaction 27806 27827	hypertriglyceridemia,
T178	adversereaction 28039 28059	Cholestatic Jaundice
T179	adversereaction 28340 28354	Hypothyroidism
T180	adversereaction 29001 29016	Fluid Retention
T181	adversereaction 29053 29069	fluid retention.
T182	adversereaction 29244 29256	Hypocalcemia
T183	adversereaction 29356 29368	hypocalcemia
T184	adversereaction 29386 29415	Exacerbation of Endometriosis
T185	adversereaction 29741 29774	exacerbate symptoms of angioedema
T186	tradename 30177 30185	ELESTRIN
T187	activeingredient 30251 30260	Estradiol
T188	tradename 30331 30339	ELESTRIN
T189	tradename 30454 30463	ELESTRIN.
T190	tradename 30506 30514	ELESTRIN
T191	activeingredient 30576 30585	estradiol
T192	tradename 30639 30647	ELESTRIN
T193	activeingredient 31065 31074	estradiol
T194	activeingredient 32378 32388	estradiol,
T195	adversereaction 32855 32879	Cardiovascular Disorders
T196	adversereaction 32946 32965	Malignant Neoplasms
T197	tradename 33474 33482	ELESTRIN
T198	tradename 33886 33894	ELESTRIN
T199	tradename 33917 33925	ELESTRIN
T200	adversereaction 33990 34007	Breast tenderness
T201	adversereaction 34033 34045	Metrorrhagia
T202	adversereaction 34122 34137	Nasopharyngitis
T203	adversereaction 34166 34200	Upper respiratory tract infection
T204	tradename 34337 34346	ELESTRIN.
T205	adversereaction 34573 34749	Changes in vaginal bleeding pattern and abnormal withdrawal bleeding or flow; breakthrough bleeding; spotting; dysmenorrhea; increase in size of uterine leiomyomata; vaginitis,
T206	adversereaction 34760 34912	vaginal candidiasis; change in amount of cervical secretion; changes in cervical ectropion; ovarian cancer; endometrial hyperplasia; endometrial cancer.
T207	adversereaction 34923 35028	Tenderness; enlargement, pain, nipple discharge, galactorrhea; fibrocystic breast changes; breast cancer.
T208	adversereaction 35046 35182	Deep and superficial venous thrombosis; pulmonary embolism; thrombophlebitis; myocardial infarction; stroke; increase in blood pressure.
T209	adversereaction 35294 35455	Nausea, vomiting; abdominal cramps, bloating; cholestatic jaundice; increased incidence of gallbladder disease; pancreatitis, enlargement of hepatic hemangiomas.
T210	adversereaction 35463 35634	Chloasma or melasma that may persist when drug is discontinued; erythema multiforme; erythema nodosum; hemorrhagic eruption; loss of scalp hair; hirsutism; pruritus, rash.
T211	adversereaction 35642 35701	Retinal vascular thrombosis, intolerance to contact lenses.
T212	adversereaction 35727 35866	Headache; migraine; dizziness; mental depression; chorea; nervousness; mood disturbances; irritability; exacerbation of epilepsy, dementia.
T213	adversereaction 35883 36147	Increase or decrease in weight; reduced carbohydrate tolerance; aggravation of porphyria; edema; arthralgias; leg cramps; changes in libido; urticaria, angioedema, anaphylactoid/anaphylactic reactions; hypocalcemia; exacerbation of asthma; increased triglycerides.
T214	tradename 36341 36350	ELESTRIN.
T215	tradename 37215 37223	ELESTRIN
T216	routeofadministration 37425 37429	oral
T217	tradename 37504 37512	ELESTRIN
T218	tradename 37808 37816	ELESTRIN
T219	tradename 37873 37881	ELESTRIN
T220	tradename 38100 38108	ELESTRIN
T221	tradename 38207 38216	ELESTRIN.
T222	frequency 38291 38296	daily
T223	dose 38301 38310	0.625 mg]
T224	frequency 38492 38497	daily
T225	dose 38502 38511	0.625 mg]
T226	dose 38522 38529	2.5 mg]
T227	adversereaction 38860 38877	probable dementia
T228	tradename 39332 39340	ELESTRIN
T229	tradename 39542 39550	ELESTRIN
T230	adversereaction 39622 39685	nausea, vomiting, breast tenderness, abdominal pain, drowsiness
T231	adversereaction 39690 39698	fatigue,
T232	adversereaction 39703 39722	withdrawal bleeding
T233	tradename 39797 39805	ELESTRIN
T234	tradename 39881 39889	ELESTRIN
T235	activeingredient 39891 39900	estradiol
T236	activeingredient 39924 39934	estradiol,
T237	tradename 40031 40039	ELESTRIN
T238	dose 40058 40065	0.52 mg
T239	activeingredient 40069 40078	estradiol
T240	dose 40082 40088	0.87 g
T241	activeingredient 40099 40108	Estradiol
T242	molecularweight 40280 40286	281.4.
T243	tradename 40340 40348	ELESTRIN
T244	activeingredient 40352 40362	estradiol.
T245	inactiveingredient 40401 40511	ethanol, propylene glycol, diethylene glycol monoethyl ether, carbomer 940, triethanolamine, edetate disodium,
T246	inactiveingredient 40525 40531	water)
T247	activeingredient 40864 40873	estradiol
T248	activeingredient 41282 41291	estradiol
T249	tradename 42149 42158	ELESTRIN.
T250	activeingredient 42232 42241	estradiol
T251	tradename 42310 42318	ELESTRIN
T252	activeingredient 42369 42378	estradiol
T253	dose 42420 42426	0.87 g
T254	dose 42430 42435	1.7 g
T255	tradename 42439 42447	ELESTRIN
T256	tradename 42509 42517	ELESTRIN
T257	dose 42518 42524	0.87 g
T258	dose 42529 42534	1.7 g
T259	activeingredient 42564 42573	estradiol
T260	activeingredient 42757 42766	estradiol
T261	dose 42859 42865	0.87 g
T262	frequency 42866 42873	per day
T263	dose 42878 42883	1.7 g
T264	frequency 42884 42891	per day
T265	frequency 42906 42913	per day
T266	frequency 42928 42936	per day,
T267	activeingredient 43002 43011	Estradiol
T268	dose 43064 43070	0.87 g
T269	tradename 43071 43079	ELESTRIN
T270	dose 43081 43089	0.52 mg/
T271	frequency 43089 43090	d
T272	activeingredient 43091 43101	Estradiol)
T273	dose 43109 43114	1.7 g
T274	tradename 43115 43123	ELESTRIN
T275	dose 43125 43133	1.04 mg/
T276	frequency 43133 43134	d
T277	activeingredient 43135 43145	Estradiol)
T278	auc 43160 43189	(pg&#x2022;hr/mL) 335.2 940.2
T279	cmax 43195 43212	(pg/mL) 21.6 66.7
T280	tmax 43263 43270	(h)a 18
T281	tmax 43272 43281	1 - 20) 4
T282	activeingredient 43472 43482	estradiol:
T283	activeingredient 43522 43531	estradiol
T284	activeingredient 43611 43620	Estradiol
T285	dose 43789 43795	0.87 g
T286	dose 43813 43818	1.7 g
T287	dose 43872 43877	1.7 g
T288	dose 43938 43943	1.7 g
T289	tradename 43952 43960	ELESTRIN
T290	tradename 44167 44175	ELESTRIN
T291	activeingredient 44202 44211	estradiol
T292	activeingredient 44267 44276	estradiol
T293	tradename 44358 44367	ELESTRIN.
T294	tradename 44459 44467	ELESTRIN
T295	activeingredient 44502 44511	estradiol
T296	tradename 44597 44606	ELESTRIN.
T297	activeingredient 45249 45258	Estradiol
T298	activeingredient 45819 45829	Estradiol,
T299	activeingredient 46085 46094	Estradiol
T300	activeingredient 46123 46132	estradiol
T301	dose 46275 46280	2.6 g
T302	tradename 46281 46289	ELESTRIN
T303	activeingredient 46432 46441	estradiol
T304	activeingredient 46548 46557	estradiol
T305	activeingredient 46741 46750	estradiol
T306	frequency 47232 47237	daily
T307	tradename 47247 47255	ELESTRIN
T308	activeingredient 47536 47545	estradiol
T309	tradename 47830 47838	ELESTRIN
T310	dose 47839 47844	1.7 g
T311	dose 47846 47853	1.04 mg
T312	activeingredient 47854 47864	estradiol)
T313	dose 47869 47874	2.6 g
T314	dose 47876 47883	1.56 mg
T315	activeingredient 47884 47894	estradiol)
T316	frequency 47895 47905	once daily
T317	tradename 47988 47996	ELESTRIN
T318	dose 48045 48050	2.6 g
T319	tradename 48085 48093	ELESTRIN
T320	dose 48094 48100	0.87 g
T321	dose 48102 48109	0.52 mg
T322	activeingredient 48110 48120	estradiol)
T323	dose 48139 48144	2.6 g
T324	tradename 48305 48313	ELESTRIN
T325	dose 48314 48319	1.7 g
T326	frequency 48320 48327	per day
T327	tradename 48517 48525	ELESTRIN
T328	dose 48526 48532	0.87 g
T329	frequency 48533 48540	per day
T330	dose 48567 48573	0.87 g
T331	frequency 48574 48581	per day
T332	dose 48586 48591	1.7 g
T333	frequency 48592 48599	per day
T334	dose 48839 48844	1.7 g
T335	frequency 48845 48852	per day
T336	tradename 48853 48861	ELESTRIN
T337	tradename 49038 49046	ELESTRIN
T338	tradename 49086 49094	ELESTRIN
T339	dose 49095 49102	0.87 g/
T340	frequency 49102 49105	day
T341	tradename 49115 49123	ELESTRIN
T342	dose 49124 49130	1.7 g/
T343	frequency 49130 49133	day
T344	frequency 50101 50106	daily
T345	routeofadministration 50107 50111	oral
T346	dose 50116 50125	0.625 mg)
T347	dose 50160 50167	2.5 mg)
T348	frequency 58564 58569	daily
T349	dose 58574 58583	0.625 mg)
T350	frequency 59702 59707	daily
T351	dose 59712 59721	0.625 mg)
T352	dose 59732 59739	2.5 mg)
T353	tradename 62641 62649	Elestrin
T354	activeingredient 62651 62660	estradiol
T355	dose 63103 63109	0.87 g
T356	dose 63132 63139	0.52 mg
T357	activeingredient 63143 63153	estradiol.
T358	tradename 63369 63377	ELESTRIN
T359	tradename 63443 63451	ELESTRIN
T360	adversereaction 64107 64153	Cardiovascular Disorders, Malignant Neoplasms,
T361	adversereaction 64158 64175	Probable Dementia
T362	adversereaction 64426 64470	headache, breast pain and tenderness, nausea
T363	adversereaction 64475 64484	vomiting.
T364	tradename 64636 64644	ELESTRIN
T365	activeingredient 64646 64655	estradiol
T366	tradename 64715 64723	ELESTRIN
T367	tradename 64772 64780	ELESTRIN
T368	tradename 65017 65025	ELESTRIN
T369	adversereaction 65123 65137	 of the uterus
T370	tradename 65212 65221	ELESTRIN.
T371	adversereaction 65281 65301	cancer of the uterus
T372	adversereaction 65688 65697	dementia,
T373	adversereaction 65935 65973	heart attacks, strokes, breast cancer,
T374	adversereaction 65977 65988	blood clots
T375	adversereaction 66068 66077	dementia,
T376	tradename 66236 66244	ELESTRIN
T377	tradename 66254 66273	ELESTRIN? ELESTRIN
T378	activeingredient 66342 66352	estradiol)
T379	routeofadministration 66362 66387	absorbed through the skin
T380	tradename 66419 66427	ELESTRIN
T381	tradename 66439 66447	ELESTRIN
T382	indication 66487 66524	Reduce moderate to severe hot flashes
T383	tradename 67501 67510	ELESTRIN.
T384	tradename 67531 67540	ELESTRIN?
T385	tradename 67561 67569	ELESTRIN
T386	tradename 67881 67890	ELESTRIN.
T387	tradename 68112 68120	ELESTRIN
T388	tradename 68178 68186	ELESTRIN
T389	tradename 69123 69131	ELESTRIN
T390	tradename 69140 69148	ELESTRIN
T391	tradename 69290 69299	ELESTRIN.
T392	tradename 69351 69359	ELESTRIN
T393	tradename 69410 69419	ELESTRIN?
T394	tradename 69537 69545	ELESTRIN
T395	tradename 69799 69818	ELESTRIN. ELESTRIN
T396	tradename 69862 69870	ELESTRIN
T397	tradename 69936 69944	ELESTRIN
T398	tradename 69998 70006	ELESTRIN
T399	tradename 70805 70814	ELESTRIN.
T400	tradename 70977 70986	ELESTRIN,
T401	tradename 71234 71242	ELESTRIN
T402	tradename 71751 71760	ELESTRIN.
T403	tradename 71880 71888	ELESTRIN
T404	tradename 71917 71925	ELESTRIN
T405	tradename 72239 72247	ELESTRIN
T406	tradename 72435 72443	ELESTRIN
T407	tradename 72517 72526	ELESTRIN?
T408	tradename 72558 72566	ELESTRIN
T409	tradename 72917 72925	ELESTRIN
T410	tradename 72950 72958	ELESTRIN
T411	tradename 73039 73048	ELESTRIN.
T412	tradename 73464 73473	ELESTRIN?
T413	adversereaction 73634 73646	Heart attack
T414	adversereaction 73657 73663	Stroke
T415	adversereaction 73789 73800	Blood clots
T416	adversereaction 73811 73819	Dementia
T417	adversereaction 73830 73843	Breast cancer
T418	adversereaction 73854 73888	Cancer of the lining of the uterus
T419	adversereaction 73906 73925	Cancer of the ovary
T420	adversereaction 73936 73955	High blood pressure
T421	adversereaction 73966 73982	High blood sugar
T422	adversereaction 73993 74012	Gallbladder disease
T423	adversereaction 74023 74037	Liver problems
T424	adversereaction 74048 74090	Enlargement of benign tumors of the uterus
T425	adversereaction 74539 74547	Headache
T426	adversereaction 74558 74569	Breast pain
T427	adversereaction 74580 74618	Irregular vaginal bleeding or spotting
T428	adversereaction 74629 74666	Stomach or abdominal cramps, bloating
T429	adversereaction 74677 74696	Nausea and vomiting
T430	adversereaction 74707 74716	Hair loss
T431	adversereaction 74727 74742	Fluid retention
T432	adversereaction 74753 74776	Vaginal yeast infection
T433	tradename 74825 74834	ELESTRIN.
T434	company 74964 74984	Meda Pharmaceuticals
T435	tradename 75227 75236	ELESTRIN?
T436	tradename 75333 75341	ELESTRIN
T437	tradename 75682 75691	ELESTRIN.
T438	tradename 76316 76324	ELESTRIN
T439	tradename 76444 76452	ELESTRIN
T440	tradename 76514 76522	ELESTRIN
T441	tradename 76611 76619	ELESTRIN
T442	tradename 76722 76731	ELESTRIN.
T443	tradename 76854 76862	ELESTRIN
T444	tradename 77893 77901	ELESTRIN
T445	tradename 78032 78041	ELESTRIN.
T446	tradename 78089 78097	ELESTRIN
T447	frequency 78120 78125	daily
T448	tradename 78220 78228	ELESTRIN
T449	tradename 78364 78372	ELESTRIN
T450	tradename 78421 78429	ELESTRIN
T451	tradename 78943 78951	ELESTRIN
T452	tradename 79059 79068	ELESTRIN?
T453	activeingredient 79089 79099	estradiol.
T454	inactiveingredient 79132 79231	water, ethanol, propylene glycol, diethylene glycol monoethyl ether, carbomer 940, triethanolamine,
T455	inactiveingredient 79236 79253	edetate disodium.
T456	tradename 79255 79263	ELESTRIN
T457	company 79282 79302	Meda Pharmaceuticals
T458	company 79321 79341	Meda Pharmaceuticals
T459	company 79434 79456	DPT Laboratories, Ltd.
T460	u.s.patent 79509 79518	7,198,801
T461	u.s.patent 79537 79546	7,470,433
